Jazz Pharmaceuticals
Robyn Barbary is a seasoned compliance professional with extensive experience in the pharmaceutical industry. Currently serving as the Director of Compliance Business Partner for the U.S. Epilepsy Movement Disorders Franchise at Jazz Pharmaceuticals since April 2022, Robyn previously held the position of Director of Healthcare Compliance at Amgen from June 2006 to March 2022. Robyn's educational background includes a Bachelor’s Degree in Political Science from Western University, obtained between 1991 and 1995.
This person is not in any teams
This person is not in any offices